A specialized gene editing system designed by scientists at the Lewis Katz School of Medicine at Temple University is paving the way to an eventual cure for patients infected with HIV, the virus that causes AIDS. In a study published online this month in the Nature journal, Scientific Reports, the researchers show that they can both effectively and safely eliminate the virus from the DNA of human cells grown in culture.
According to senior investigator on the new study, Kamel Khalili, PhD, Laura H. Carnell Professor and Chair of the Department of Neuroscience, Director of the Center for Neurovirology, and Director of the Comprehensive NeuroAIDS Center at the Lewis Katz School of Medicine at Temple University (LKSOM), “Antiretroviral drugs are very good at controlling HIV infection. But patients on antiretroviral therapy who stop taking the drugs suffer a rapid rebound in HIV replication.” The presence of numerous copies of HIV weakens the immune system and eventually causes acquired immune deficiency syndrome, or AIDS.
Curing HIV/AIDS – which has claimed the lives of more than 25 million people since it was first discovered in the 1980s – is the ultimate goal in HIV research. But eliminating the virus after it has become integrated into CD4+ T-cells, the cells primarily infected with HIV, has proven difficult. Recent attempts have focused on intentionally reactivating HIV, aiming to stimulate a robust immune response capable of eradicating the virus from infected cells. However, to date, none of these “shock and kill” approaches has been successful.
Dr. Khalili and colleagues decided to try a different approach, specifically targeting HIV-1 proviral DNA (the integrated viral genome) using uniquely tailored gene editing technology. Their system includes a guide RNA that specifically locates HIV-1 DNA in the T-cell genome, and a nuclease enzyme, which cuts the strands of T-cell DNA. Once the nuclease has edited out the HIV-1 DNA sequence, the loose ends of the genome are reunited by the cell’s own DNA repair machinery.
In previous work, Dr. Khalili’s team had demonstrated the ability of their technology to snip out HIV-1 DNA from human cell lines. In their latest study, however, they concentrated on latently and productively infected CD4+ T cells to show not only that the technology eliminates the virus from cells but also that its persistent presence in HIV-1-eradicated cells actually protects them against reinfection. More importantly, they carried their work over to ex vivo experiments, in which T-cells from patients infected with HIV were grown in cell culture, showing that treatment with the gene editing system can suppress viral replication and dramatically reduce viral load in patient cells.
In another major component of the study, Dr. Khalili’s team addressed questions about off-target effects and toxicity. Using an approach known as ultra-deep whole-genome sequencing, which is considered the gold standard for genomic assessment, the researchers analyzed the genomes of HIV-1-eradicated cells for mutations in genes outside the region targeted by the guide RNA. Their analyses ruled out off-target effects on genes, including potential collateral effects on cellular gene expression. Studies of cell viability and proliferation showed that HIV-1-eradicated cells were growing and functioning normally.
“The findings are important on multiple levels,” Dr. Khalili said. “They demonstrate the effectiveness of our gene editing system in eliminating HIV from the DNA of CD4 T-cells and, by introducing mutations into the viral genome, permanently inactivating its replication. Further, they show that the system can protect cells from reinfection and that the technology is safe for the cells, with no toxic effects.”
“These experiments had not been performed previously to this extent,” he added. “But the questions they address are critical, and the results allow us to move ahead with this technology.”
The Latest on: HIV/AIDS
[google_news title=”” keyword=”HIV/AIDS” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: HIV/AIDS
- Multidisciplinary approach needed against rising HIV/AIDS: Bong Goon November 18, 2023 at 7:43 pm
SENATOR Christopher “Bong” Go called for a multidisciplinary approach to address the rising cases of HIV/AIDS in the country. Go, the senate committee chair on health, stressed the need to strengthen ...
- Alliance for Positive Health still fights to combat stigma around HIVon November 18, 2023 at 4:00 pm
Formerly known as the AIDS Council of Northeastern New York ... Still, the agency’s core mission remains identifying people newly infected and those living long term with HIV who have not connected ...
- Revitalizing Efforts to Bring an End to the HIV/AIDS Epidemicon November 17, 2023 at 10:45 am
By John Cunningham One of my closest friends, Joe, was a bright light for all who knew him. He warmed their lives and impacted mine in a way few others have. Just last month, he passed away from AIDS ...
- ‘Without them, a lot of people wouldn’t survive’: Budget fight in Congress putting HIV/AIDS care at riskon November 17, 2023 at 3:00 am
Federal funding for programs that provide housing, food, medicine and case management care for people living with HIV is up in the air as Congress keeps kicking the funding can down the road.
- CRC conduct HIV/AIDS outreachon November 16, 2023 at 11:15 pm
In preparation for World AIDS Day on December 1, the Cambodian Red Cross (CRC) is conducting educational outreach under the theme “One Community Leads to Ending AIDS”.
- Report lists hurdles in HIV/Aids fighton November 15, 2023 at 10:31 pm
Officials note that the rate of reduction in the number of new HIV infections isn’t in tandem with ending Aids as a public health threat by 2030.
- Government of Canada supports community-based projects to address HIV, Hepatitis C, and other sexually transmitted and blood-borne infectionson November 15, 2023 at 7:31 pm
Today, during a visit to the Nine Circles Community Health Centre, the Honourable Mark Holland, Minister of Health, announced $14.4 million through the HIV and Hepatitis C Community Action Fund (CAF) ...
- Health unit offering at home HIV testing serviceon November 15, 2023 at 12:52 pm
The testing process involves a simple blood sample obtained from a fingertip, which is then analyzed for HIV antibodies using the included testing device. Each kit comes complete ...
- Injectable HIV drug less accessible to patients in B.C.: doctoron November 13, 2023 at 8:20 am
British Columbians with HIV have less access to an injectable drug compared to patients elsewhere in the country who can get a shot every two months instead of taking a daily pill, says an infectious ...
- This doctor treated HIV/AIDS patients when no one else would. His advocacy continued as he prepared to dieon November 8, 2023 at 10:45 am
A Winnipeg doctor hopes his legacy of providing health care to LGBTQ patients — one of only a few local physicians doing so at the height of the HIV/AIDS crisis — extends beyond his life.
via Bing News